InvestorsHub Logo
Followers 0
Posts 213
Boards Moderated 0
Alias Born 07/31/2017

Re: BuddyLou post# 6311

Tuesday, 06/26/2018 5:48:04 PM

Tuesday, June 26, 2018 5:48:04 PM

Post# of 18220
IF IMUN is listed in such report, and many in the field become interested what will they find in their obvious DD based on eagerness to obtain information about IMUN's CAR-T technology.

It is the purported Chimeric Super Antigen Receptor T cell cocktail therapy promulgated by Professor Fengping Shan. Has anyone heard of any progress made on this over last two years?

One thing to be listed with the types of corporations in the report-but another to be able to credibly demonstrate some interesting potential therapy results. Are there any? If there are, why has this not been reported, This is as the report title states "..The Most Hot Topic Discussed Among Oncologists Throughout The Globe."

Do you want the stock value to be increased? What has been happening? Any presentations at scientific meetings? Any publications of any nature covering this purported CAR-T cocktail therapy? Must be-IMUN is in the report.